E
Evolent Health, Inc. (EVH)
NYQ – Real Time Price. Currency in USD
4.16
+0.20 (5.05%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NYQ – Real Time Price. Currency in USD
4.16
+0.20 (5.05%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.32 | 2.19 | 7.0 | |
| Quick ratio | 1.32 | 1.96 | 7.0 | |
| Debt to Equity | 2.49 | 1.16 | 2.0 | |
| Debt to Assets | 0.52 | 2.94 | 4.0 | |
| Interest coverage | -0.60 | -28.30 | 1.0 | |
| Weighted average score | 4.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 1.35B | 1.96B | 2.55B | 1.88B | 1.89B |
| Gross Profit | 246M | 337M | 248M | 284M | 267M |
| Operating Income | 5M | 31M | 2M | -4M | -16M |
| Net Income | -19M | -113M | -62M | -535M | -497M |
| EBITDA | 95M | 154M | 126M | 111M | 102M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 35.14 | 76.16 | 10 |
| Next quarter | 40.37 | 19.87 | 9.5 |
| Current year | 32.63 | 68.07 | 10 |
| Next year | 16.34 | 167.4 | 9.5 |
| Weighted average score | 9.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 5.87 | 93.79 | -124.99 | -118 | 4.3 |
| Y/Y | 2.6 | 58.79 | -133.32 | -83.36 | 4.0 |
| 3y average | 16.27 | -409.17 | -46.43 | 133.43 | 5.3 |
| 5y average | 19.18 | -219.46 | 924.04 | 13.56 | 7.0 |
| Weighted average score | 5.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $985.4M significantly exceeds cash reserves ($166.0M), raising financial stability concerns
Total current assets $502.0M exceed Total current liabilities $381.2M, highlighting excellent liquidity
Debt-to-equity ratio (2.5) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-0.6x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$7.4M limits the company's ability to reinvest or pay down debt